Ms. McClain is a member of the firm's litigation group, where she concentrates her practice in complex litigation, including antitrust class actions. Recent significant class actions she has been involved in include the Brand Name Prescription Drugs Antitrust Litigation (settlements well over $700 million), and High Fructose Corn Syrup Antitrust Litigation (with an anticipated trial in early 2001).